Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -74.92M | $ -7.24 | 1 | 10.35M |
3/31/2025 | $ -78.91M | $ -9.38 | 1 | 8.41M |
12/31/2024 | $ -80.74M | $ -12.89 | 1 | 6.26M |
9/30/2024 | $ -85M | $ -13.55 | 1 | 6.27M |
6/30/2024 | $ -85.23M | $ -13.62 | 1 | 6.26M |
3/31/2024 | $ -79.36M | $ -12.7 | 1 | 6.25M |
12/31/2023 | $ -79M | $ -30.73 | 1 | 2.57M |
9/30/2023 | $ -73.12M | $ -42.03 | 1 | 1.74M |
6/30/2023 | $ -69.92M | $ -40.45 | 1 | 1.73M |
3/31/2023 | $ -81.34M | $ -47.39 | 1 | 1.72M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for ALIGOS THERAPEUTICS INC is calculated as follows: CF - Operations [ $ 0 ] / (Shares WA [ 121.11K ] * Share Factor [ 1 ])
(=) OCFPS [ $ 0 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.66 |
median | $ 0.9 |
std | $ 3.42 |